<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Liang Q</submitter><pubmed_abstract>&lt;i>Listeria monocytogenes&lt;/i> (LM) induces efficient and specific T-cell immune responses in the host. Listeriolysin O (LLO) is the main virulence protein of LM. LLO helps LM escape from the lysosome. However, the pronounced pathogenicity of LM limits its practical application as a live bacterial vector. &lt;i>Listeria ivanovii&lt;/i> (LI) also displays intracellular parasitic abilities, cell to cell transfer, and other LM properties, with an elevated biosafety relative to LM. We have confirmed that LI can be used as a viable bacterial vaccine vector. However, we have also observed &lt;i>in vivo&lt;/i> that LI vector vaccine candidates survive in the immune organ (spleen) for a shorter time compared with the survival time of LM and elicit weaker immune responses compared with LM. Studies have confirme</pubmed_abstract><journal>Frontiers in microbiology</journal><pagination>962326</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9355162</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Recombinant &lt;i>Listeria ivanovii&lt;/i> strain expressing listeriolysin O in place of ivanolysin O might be a potential antigen carrier for vaccine construction.</pubmed_title><pmcid>PMC9355162</pmcid><pubmed_authors>Ou Q</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Tian S</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Liang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Recombinant &lt;i>Listeria ivanovii&lt;/i> strain expressing listeriolysin O in place of ivanolysin O might be a potential antigen carrier for vaccine construction.</name><description>&lt;i>Listeria monocytogenes&lt;/i> (LM) induces efficient and specific T-cell immune responses in the host. Listeriolysin O (LLO) is the main virulence protein of LM. LLO helps LM escape from the lysosome. However, the pronounced pathogenicity of LM limits its practical application as a live bacterial vector. &lt;i>Listeria ivanovii&lt;/i> (LI) also displays intracellular parasitic abilities, cell to cell transfer, and other LM properties, with an elevated biosafety relative to LM. We have confirmed that LI can be used as a viable bacterial vaccine vector. However, we have also observed &lt;i>in vivo&lt;/i> that LI vector vaccine candidates survive in the immune organ (spleen) for a shorter time compared with the survival time of LM and elicit weaker immune responses compared with LM. Studies have confirme</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-26T14:15:36.502Z</modification><creation>2025-02-19T05:05:32.549Z</creation></dates><accession>S-EPMC9355162</accession><cross_references><pubmed>35935244</pubmed><doi>10.3389/fmicb.2022.962326</doi></cross_references></HashMap>